18 0 2 0 2 B-lower_bound
years 3 8 3 8 I-lower_bound
of 9 11 9 11 O
age 12 15 12 15 B-age
and 16 19 16 19 O
up 20 22 20 22 O

Active 0 6 23 29 B-chronic_disease
, 6 7 29 30 O
uncontrolled 8 20 31 43 B-chronic_disease
bacterial 21 30 44 53 I-chronic_disease
, 30 31 53 54 O
viral 32 37 55 60 B-chronic_disease
, 37 38 60 61 O
or 39 41 62 64 O
fungal 42 48 65 71 B-chronic_disease
infections 49 59 72 82 I-chronic_disease
, 59 60 82 83 O
requiring 61 70 84 93 O
systemic 71 79 94 102 B-treatment
therapy 80 87 103 110 I-treatment

All 0 3 111 114 O
radiology 4 13 115 124 B-treatment
scans 14 19 125 130 I-treatment
must 20 24 131 135 O
be 25 27 136 138 O
performed 28 37 139 148 O
within 38 44 149 155 O
28 45 47 156 158 B-upper_bound
days 48 52 159 163 I-upper_bound
prior 53 58 164 169 I-upper_bound
to 59 61 170 172 O
registration 62 74 173 185 O

Allocated 0 9 186 195 O
to 10 12 196 198 O
receive 13 20 199 206 O
Gemcitabine 21 32 207 218 B-treatment
+ 33 34 219 220 O
nab 35 38 221 224 B-treatment
- 38 39 224 225 I-treatment
Paclitaxel 39 49 225 235 I-treatment
as 50 52 236 238 O
first 53 58 239 244 O
line 59 63 245 249 O
treatment 64 73 250 259 B-treatment

Any 0 3 260 263 O
evidence 4 12 264 272 O
of 13 15 273 275 O
ascites 16 23 276 283 B-chronic_disease
( 24 25 284 285 O
beyond 25 31 285 291 O
trace 32 37 292 297 O
) 37 38 297 298 O

Any 0 3 299 302 O
prior 4 9 303 308 B-treatment
therapy 10 17 309 316 I-treatment
for 18 21 317 320 O
the 22 25 321 324 O
treatment 26 35 325 334 B-treatment
of 36 38 335 337 O
pancreatic 39 49 338 348 B-cancer
malignancy 50 60 349 359 I-cancer

At 0 2 360 362 O
least 3 8 363 368 O
one 9 12 369 372 B-lower_bound
site 13 17 373 377 O
of 18 20 378 380 O
disease 21 28 381 388 O
must 29 33 389 393 O
be 34 36 394 396 O
unidimensionally 37 53 397 413 O
measurable 54 64 414 424 O

Bulky 0 5 425 430 B-clinical_variable
celiac 6 12 431 437 I-clinical_variable
adenopathy 13 23 438 448 I-clinical_variable
( 24 25 449 450 O
≥2.5 25 29 450 454 O
cm 30 32 455 457 I-lower_bound
) 32 33 457 458 O

Evidence 0 8 459 467 O
of 9 11 468 470 O
metastatic 12 22 471 481 B-chronic_disease
disease 23 30 482 489 I-chronic_disease

Females 0 7 490 497 B-gender
who 8 11 498 501 O
are 12 15 502 505 O
pregnant 16 24 506 514 B-pregnancy

Have 0 4 515 519 O
a 5 6 520 521 O
target 7 13 522 528 O
tumor 14 19 529 534 B-cancer
that 20 24 535 539 O
is 25 27 540 542 O
accessible 28 38 543 553 O
for 39 42 554 557 O
intratumoral 43 55 558 570 O
administration 56 70 571 585 O
by 71 73 586 588 O
EUS 74 77 589 592 B-treatment
( 78 79 593 594 I-treatment
Endoscopic 79 89 594 604 I-treatment
Ultrasound 90 100 605 615 I-treatment
) 100 101 615 616 I-treatment
guidance 102 110 617 625 O
as 111 113 626 628 O
determined 114 124 629 639 O
by 125 127 640 642 O
the 128 131 643 646 O
radiologist 132 143 647 658 O
/ 143 144 658 659 O
gastroenterologist 144 162 659 677 O
performing 163 173 678 688 O
the 174 177 689 692 O
EUS 178 181 693 696 B-treatment
insertion 182 191 697 706 I-treatment

Have 0 4 707 711 O
an 5 7 712 714 O
ECOG 8 12 715 719 B-clinical_variable
performance 13 24 720 731 I-clinical_variable
status 25 31 732 738 I-clinical_variable
of 32 34 739 741 O
≤ 35 36 742 743 O
1 37 38 744 745 B-upper_bound

Have 0 4 746 750 O
an 5 7 751 753 O
unresectable 8 20 754 766 O
, 20 21 766 767 O
locally 22 29 768 775 O
advanced 30 38 776 784 O
pancreatic 39 49 785 795 B-cancer
cancer 50 56 796 802 I-cancer
( 57 58 803 804 O
AJCC 58 62 804 808 B-cancer
stage 63 68 809 814 I-cancer
III 69 72 815 818 I-cancer
) 72 73 818 819 O

Have 0 4 820 824 O
serum 5 10 825 830 B-clinical_variable
creatinine 11 21 831 841 I-clinical_variable
< 22 23 842 843 O
1.6 23 26 843 846 B-upper_bound
mg 27 29 847 849 I-upper_bound
/ 29 30 849 850 I-upper_bound
dL 30 32 850 852 I-upper_bound
, 32 33 852 853 O
INR 34 37 854 857 B-clinical_variable
< 38 39 858 859 O
1.5 40 43 860 863 B-upper_bound
U 44 45 864 865 I-upper_bound
, 45 46 865 866 O
absolute 47 55 867 875 B-clinical_variable
neutrophil 56 66 876 886 I-clinical_variable
count 67 72 887 892 I-clinical_variable
( 73 74 893 894 I-clinical_variable
ANC 74 77 894 897 I-clinical_variable
) 77 78 897 898 I-clinical_variable
> 79 80 899 900 O
1.5 81 84 901 904 B-lower_bound
x 85 86 905 906 I-lower_bound
109 87 90 907 910 I-lower_bound
/ 90 91 910 911 I-lower_bound
L 91 92 911 912 I-lower_bound
, 93 94 913 914 O
platelets 95 104 915 924 B-clinical_variable
≥ 105 106 925 926 O
100 107 110 927 930 B-lower_bound
x 111 112 931 932 I-lower_bound
109 113 116 933 936 I-lower_bound
/ 116 117 936 937 I-lower_bound
L 117 118 937 938 I-lower_bound
, 119 120 939 940 O
hemoglobin 121 131 941 951 B-clinical_variable
≥ 132 133 952 953 O
9 134 135 954 955 B-lower_bound
mg 136 138 956 958 I-lower_bound
/ 138 139 958 959 I-lower_bound
dL 139 141 959 961 I-lower_bound
, 141 142 961 962 O
ALT 143 146 963 966 B-clinical_variable
and 147 150 967 970 O
AST 151 154 971 974 B-clinical_variable
≤ 155 156 975 976 O
5 157 158 977 978 B-upper_bound
x 159 160 979 980 I-upper_bound
ULN 161 164 981 984 I-upper_bound
, 164 165 984 985 O
bilirubin 166 175 986 995 B-clinical_variable
≤ 176 177 996 997 O
1.5 178 181 998 1001 B-upper_bound
x 182 183 1002 1003 I-upper_bound
ULN 184 187 1004 1007 I-upper_bound

History 0 7 1008 1015 O
of 8 10 1016 1018 O
clinically 11 21 1019 1029 O
significant 22 33 1030 1041 O
coagulopathy 34 46 1042 1054 B-chronic_disease

Known 0 5 1055 1060 O
active 6 12 1061 1067 B-chronic_disease
infection 13 22 1068 1077 I-chronic_disease
with 23 27 1078 1082 O
HIV 28 31 1083 1086 B-chronic_disease

Known 0 5 1087 1092 O
allergy 6 13 1093 1100 O
to 14 16 1101 1103 O
sesame 17 23 1104 1110 B-allergy_name
oil 24 27 1111 1114 I-allergy_name

Major 0 5 1115 1120 B-treatment
surgery 6 13 1121 1128 I-treatment
, 13 14 1128 1129 O
other 15 20 1130 1135 O
than 21 25 1136 1140 O
diagnostic 26 36 1141 1151 B-treatment
surgery 37 44 1152 1159 I-treatment
, 44 45 1159 1160 O
within 46 52 1161 1167 O
4 53 54 1168 1169 B-upper_bound
weeks 55 60 1170 1175 I-upper_bound
prior 61 66 1176 1181 O
to 67 69 1182 1184 O
Day 70 73 1185 1188 O
1 74 75 1189 1190 O
, 75 76 1190 1191 O
without 77 84 1192 1199 O
complete 85 93 1200 1208 O
recovery 94 102 1209 1217 O

Men 0 3 1218 1221 B-gender

New 0 3 1222 1225 B-clinical_variable
York 4 8 1226 1230 I-clinical_variable
Heart 9 14 1231 1236 I-clinical_variable
Association 15 26 1237 1248 I-clinical_variable
( 27 28 1249 1250 I-clinical_variable
NYHA 28 32 1250 1254 I-clinical_variable
) 32 33 1254 1255 I-clinical_variable
Class 34 39 1256 1261 I-clinical_variable
III 40 43 1262 1265 B-lower_bound
or 44 46 1266 1268 O
IV 47 49 1269 1271 B-upper_bound

Other 0 5 1272 1277 O
malignancy 6 16 1278 1288 B-cancer
that 17 21 1289 1293 O
would 22 27 1294 1299 O
interfere 28 37 1300 1309 O
with 38 42 1310 1314 O
the 43 46 1315 1318 O
current 47 54 1319 1326 O
intervention 55 67 1327 1339 O

Previously 0 10 1340 1350 O
treated 11 18 1351 1358 O
malignancies 19 31 1359 1371 B-cancer

Prior 0 5 1372 1377 B-treatment
therapy 6 13 1378 1385 I-treatment
with 14 18 1386 1390 I-treatment
any 19 22 1391 1394 I-treatment
hypoxic 23 30 1395 1402 I-treatment
cytotoxin 31 40 1403 1412 I-treatment
( 41 42 1413 1414 I-treatment
hypoxia 42 49 1414 1421 I-treatment
- 49 50 1421 1422 I-treatment
targeting 50 59 1422 1431 I-treatment
drugs 60 65 1432 1437 I-treatment
) 65 66 1437 1438 I-treatment

Severe 0 6 1439 1445 O
chronic 7 14 1446 1453 B-chronic_disease
obstructive 15 26 1454 1465 I-chronic_disease
or 27 29 1466 1468 O
other 30 35 1469 1474 O
pulmonary 36 45 1475 1484 B-chronic_disease
disease 46 53 1485 1492 I-chronic_disease
with 54 58 1493 1497 O
hypoxemia 59 68 1498 1507 B-chronic_disease
( 69 70 1508 1509 O
requires 70 78 1509 1517 O
supplementary 79 92 1518 1531 O
oxygen 93 99 1532 1538 O
, 99 100 1538 1539 O
symptoms 101 109 1540 1548 O
due 110 113 1549 1552 O
to 114 116 1553 1555 O
hypoxemia 117 126 1556 1565 O
or 127 129 1566 1568 O
oxygen 130 136 1569 1575 B-clinical_variable
saturation 137 147 1576 1586 I-clinical_variable
< 148 149 1587 1588 O
90 149 151 1588 1590 B-upper_bound
% 151 152 1590 1591 I-upper_bound
by 153 155 1592 1594 O
pulse 156 161 1595 1600 B-treatment
oximetry 162 170 1601 1609 I-treatment
after 171 176 1610 1615 O
a 177 178 1616 1617 O
2 179 180 1618 1619 O
minute 181 187 1620 1626 O
walk 188 192 1627 1631 O
) 192 193 1631 1632 O
or 194 196 1633 1635 O
in 197 199 1636 1638 O
the 200 203 1639 1642 O
opinion 204 211 1643 1650 O
of 212 214 1651 1653 O
the 215 218 1654 1657 O
investigator 219 231 1658 1670 O
any 232 235 1671 1674 O
physiological 236 249 1675 1688 O
state 250 255 1689 1694 O
likely 256 262 1695 1701 O
to 263 265 1702 1704 O
cause 266 271 1705 1710 O
systemic 272 280 1711 1719 O
or 281 283 1720 1722 O
regional 284 292 1723 1731 O
hypoxemia 293 302 1732 1741 O

Subjects 0 8 1742 1750 O
who 9 12 1751 1754 O
participated 13 25 1755 1767 O
in 26 28 1768 1770 O
an 29 31 1771 1773 O
investigational 32 47 1774 1789 B-treatment
drug 48 52 1790 1794 I-treatment
or 53 55 1795 1797 O
device 56 62 1798 1804 B-treatment
study 63 68 1805 1810 I-treatment
within 69 75 1811 1817 O
28 76 78 1818 1820 B-upper_bound
days 79 83 1821 1825 I-upper_bound
prior 84 89 1826 1831 I-upper_bound
to 90 92 1832 1834 O
study 93 98 1835 1840 O
entry 99 104 1841 1846 O

Subjects 0 8 1847 1855 O
with 9 13 1856 1860 O
resectable 14 24 1861 1871 O
and 25 28 1872 1875 O
borderline 29 39 1876 1886 B-cancer
resectable 40 50 1887 1897 I-cancer
pancreatic 51 61 1898 1908 I-cancer
cancer 62 68 1909 1915 I-cancer

adequately 0 10 1916 1926 O
treated 11 18 1927 1934 O
non 19 22 1935 1938 B-cancer
- 22 23 1938 1939 I-cancer
melanoma 23 31 1939 1947 I-cancer
skin 32 36 1948 1952 I-cancer
cancer 37 43 1953 1959 I-cancer

cardiac 0 7 1960 1967 B-chronic_disease
disease 8 15 1968 1975 I-chronic_disease

chemotherapy 0 12 1976 1988 B-treatment

hepatitis 0 9 1989 1998 B-chronic_disease
B 10 11 1999 2000 I-chronic_disease
virus 12 17 2001 2006 I-chronic_disease

hepatitis 0 9 2007 2016 B-chronic_disease
C 10 11 2017 2018 I-chronic_disease
virus 12 17 2019 2024 I-chronic_disease

immunotherapy 0 13 2025 2038 B-treatment

in 0 2 2039 2041 B-cancer
situ 3 7 2042 2046 I-cancer
cancer 8 14 2047 2053 I-cancer

major 0 5 2054 2059 B-treatment
surgery 6 13 2060 2067 I-treatment

monoclonal 0 10 2068 2078 B-treatment
antibodies 11 21 2079 2089 I-treatment

myocardial 0 10 2090 2100 B-chronic_disease
infarction 11 21 2101 2111 I-chronic_disease
within 22 28 2112 2118 O
4months 29 36 2119 2126 B-upper_bound
prior 37 42 2127 2132 I-upper_bound
to 43 45 2133 2135 O
Day 46 49 2136 2139 O
1 50 51 2140 2141 O

nonadenocarcinoma 0 17 2142 2159 O
histology 18 27 2160 2169 O

other 0 5 2170 2175 O
cancers 6 13 2176 2183 B-cancer
from 14 18 2184 2188 O
which 19 24 2189 2194 O
the 25 28 2195 2198 O
subject 29 36 2199 2206 O
has 37 40 2207 2210 O
been 41 45 2211 2215 O
disease 46 53 2216 2223 O
- 53 54 2223 2224 O
free 54 58 2224 2228 O
for 59 62 2229 2232 O
at 63 65 2233 2235 O
least 66 71 2236 2241 O
2 72 73 2242 2243 B-lower_bound
years 74 79 2244 2249 I-lower_bound

symptomatic 0 11 2250 2261 O
peripheral 12 22 2262 2272 B-chronic_disease
arterial 23 31 2273 2281 I-chronic_disease
vascular 32 40 2282 2290 I-chronic_disease
disease 41 48 2291 2298 I-chronic_disease

unstable 0 8 2299 2307 O
arrhythmia 9 19 2308 2318 B-chronic_disease

women 0 5 2319 2324 B-gender
patients 6 14 2325 2333 O

